FDA says more data needed to approve dry eye drug Aldeyra (NASDAQ:ALDX)
Iryna Drozd The FDA has refused to approve Aldeyra Therapeutics (NASDAQ:ALDX) drug reproxalap, citing insufficient evidence that the drug was ...
Tag: Aldeyra
Recommended.
